Lidia Tagliafierro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lidia Tagliafierro has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Esposito
Department of Medicine, Section of Hematology Oncology, Thoracic Oncology Program, The University of Chicago, Chicago, USA
2 shared publications - Helen Willcockson
Division of Rheumatology, Allergy and Immunology and the Thurston Arthritis Research Center, University of North Carolina-Chapel Hill, NC, USA
2 shared publications - Lara Longobardi
Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
2 shared publications - Anna Spagnoli
Department of Pediatrics, Rush University Medical Center, Chicago, IL, USA
1 shared publication - Anna Spagnoli
Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
1 shared publication - Aysegul Dilsizoglu Senol
INSERM UMR 894, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.
1 shared publication
Latest Publications
- 1 June 2017
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 25 (6) , 914-925
Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis
- 1 June 2017
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 25 (6) , 914-925
Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis
- Open Access
- 7 March 2015
- Published by Springer Nature in BMC Neuroscience
- Vol. 16 (1) , 10
PAT1 inversely regulates the surface Amyloid Precursor Protein level in mouse primary neurons
The amyloid precursor protein (APP) is a key molecule in Alzheimer disease. Its localization at the cell surface can trigger downstream signaling and APP cleavages. APP trafficking to the cell surface in neurons is not clearly understood and may be related to the interactions with its partners. In this respect, by having homologies with kinesin light chain domains and because of its capacity to bind APP, PAT1 represents a good candidate. We observed that PAT1 binds poorly APP at the cell surface of primary cortical neurons contrary to cytoplasmic APP. Using down and up-regulation of PAT1, we observed respectively an increase and decrease of APP at the cell surface. The increase of APP at the cell surface induced by low levels of PAT1 did not trigger cell death signaling. These data suggest that PAT1 slows down APP trafficking to the cell surface in primary cortical neurons. Our results contribute to the elucidation of mechanisms involved in APP trafficking in Alzheimer disease.
- 7 March 2015
- Published by Springer Nature in BMC Neuroscience
- Vol. 16 (1) , 10
Open AccessPAT1 inversely regulates the surface Amyloid Precursor Protein level in mouse primary neurons
The amyloid precursor protein (APP) is a key molecule in Alzheimer disease. Its localization at the cell surface can trigger downstream signaling and APP cleavages. APP trafficking to the cell surface in neurons is not clearly understood and may be related to the interactions with its partners. In this respect, by having homologies with kinesin light chain domains and because of its capacity to bind APP, PAT1 represents a good candidate. We observed that PAT1 binds poorly APP at the cell surface of primary cortical neurons contrary to cytoplasmic APP. Using down and up-regulation of PAT1, we observed respectively an increase and decrease of APP at the cell surface. The increase of APP at the cell surface induced by low levels of PAT1 did not trigger cell death signaling. These data suggest that PAT1 slows down APP trafficking to the cell surface in primary cortical neurons. Our results contribute to the elucidation of mechanisms involved in APP trafficking in Alzheimer disease.
- 28 November 2014
- Published by Springer Nature in Current Osteoporosis Reports
- Vol. 13 (1) , 41-51
Synovial Joints: from Development to Homeostasis
Synovial joint morphogenesis occurs through the condensation of mesenchymal cells into a non-cartilaginous region known as the interzone and the specification of progenitor cells that commit to the articular fate. Although several signaling molecules are expressed by the interzone, the mechanism is poorly understood. For treatments of cartilage injuries, it is critical to discover the presence of joint progenitor cells in adult tissues and their expression gene pattern. Potential stem cell niches have been found in different joint regions, such as the surface zone of articular cartilage, synovium, and groove of Ranvier. Inherited joint malformations as well as joint-degenerating conditions are often associated with other skeletal defects and may be seen as the failure of morphogenic factors to establish the correct microenvironment in cartilage and bone. Therefore, exploring how joints form can help us understand how cartilage and bone are damaged and develop drugs to reactivate this developing mechanism.
- 28 November 2014
- Published by Springer Nature in Current Osteoporosis Reports
- Vol. 13 (1) , 41-51
Synovial Joints: from Development to Homeostasis
Synovial joint morphogenesis occurs through the condensation of mesenchymal cells into a non-cartilaginous region known as the interzone and the specification of progenitor cells that commit to the articular fate. Although several signaling molecules are expressed by the interzone, the mechanism is poorly understood. For treatments of cartilage injuries, it is critical to discover the presence of joint progenitor cells in adult tissues and their expression gene pattern. Potential stem cell niches have been found in different joint regions, such as the surface zone of articular cartilage, synovium, and groove of Ranvier. Inherited joint malformations as well as joint-degenerating conditions are often associated with other skeletal defects and may be seen as the failure of morphogenic factors to establish the correct microenvironment in cartilage and bone. Therefore, exploring how joints form can help us understand how cartilage and bone are damaged and develop drugs to reactivate this developing mechanism.